Molecular simulations show how drugs block key receptors

Many pharmaceuticals work by targeting what are known as 'G-protein-coupled receptors.' In a new study, scientists from Uppsala University describe how they have been able to predict how special molecules that can be used ...

Click... Resistant bacteria caught in the act

As humanity fights against the coronavirus, the battle against antibiotic-resistant bacteria continues. Scientists at UCLouvain have succeeded in capturing unique images of protein soldiers that help bacteria resist drugs. ...

Platform turbo-boosts development of new antibiotics

Harmful bacteria react less and less to common antibiotics. The infections they cause are therefore increasingly deadly. World health therefore urgently needs alternative antibacterial agents. "Our VersaTile platform gives ...

Nanomaterial significantly enhances potential COVID-19 therapy

Niclosamide, a drug used to treat tapeworms, has been found to have strong antiviral effect against SARS-CoV-2, the virus causing the COVID-19 pandemic. But the drug itself has limited potential because its structure makes ...

COVID-19: A wake-up call to rebalance the drug supply chain?

Over 80% of chemicals used to make pharmaceuticals sold in Europe originate from China or India, according to the European Fine Chemicals Group. When COVID-19 emerged in Wuhan and spread across the globe, experts worried ...

page 26 from 40